Home
Conditions
Malignant Pleural Effusion

Clinical trial condition

Malignant Pleural Effusion

Explore clinical trials studying Malignant Pleural Effusion. Study availability and eligibility vary by location and protocol.

39 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Malignant Pleural Effusion trial results

Completed

FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer

NCT00564733

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
Locations: Harborview Medical Center Seattle, Washington, United States

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

The First Therapeutic Intervention in Malignant Pleural Effusion Trial

NCT00896285

Conditions: Malignant Pleural Effusion, Neoplasms, Neoplasms by Site, +7 more
Locations: UC Davis Medical Center Sacramento, California, United States

View Trial Details

Completed

Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer

NCT01661790

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: PLA 304 hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites

NCT01327235

Conditions: Malignant Ascites, Malignant Pleural Effusion, Neoplasms, +8 more
Locations: The 81st Hospital of Chinese PLA Nanjing, China

The Affiliated Hospital of Medical College, QingDao University Qingdao, China

Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Completed

Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion Patients

NCT02191540

Conditions: Malignant Pleural Effusion, Neoplasms, Neoplasms by Site, +7 more
Locations: Busan University Hospital Busan, South Korea

Chonnam National University Hwasun hospital Hwasun Gun, Jeollanam-do, South Korea

Ulsan University Hospital Ulsan, South Korea

View Trial Details

Completed

Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00118183

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +24 more
Locations: Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States

View Trial Details

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

NCT00052338

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations: City of Hope Duarte, California, United States

View Trial Details

Active, Not Recruiting

A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions

NCT04914598

Conditions: Malignant Pleural Effusion, Neoplasms, Neoplasms by Site, +7 more
Locations: Yan Xie Nanjing, China

View Trial Details

Malignant Pleural Effusion

Malignant Pleural Effusion trial results

Related conditions